Objective evaluation of physical and drug therapy in the rehabilitation of the hemiplegic patient. I. A study of dihydroergocornine (DHO-180).
D002317:Cardiovascular Agents; D025441:Dihydroergocornine; D004876:Ergot Alkaloids / Q000627:therapeutic use*; D006429:Hemiplegia / Q000628:therapy*; D006801:Humans; D010808:Physical Examination
D002317:Cardiovascular Agents; D004876:Ergot Alkaloids; D025441:Dihydroergocornine
ERGOT ALKALOIDS/therapeutic use; HEMIPLEGIA/therapy